Meet the team: Arun Flynn
As a child, Arun’s mum always thought he would grow up to become an inventor because he was always trying to understand how the things around him worked and then how he could fix them. This fascination then transformed into a focus towards the human body, how it works and how diseases are formed and […]
From Startup to a trusted CRO: Reflections on 10 Years of Cellomatics
To mark Cellomatics’ 10 year anniversary, our CEO and Founder Dr Shailendra Singh shares his thoughts on the journey that Cellomatics has been on and what he has learnt over the last decade. Over the past decade at Cellomatics Biosciences, we’ve been focused on a simple but important goal: improving how we model human biology […]
Meet the team: Klaudia Magdalena Rzepecka
Klaudia has been working at Cellomatics as a Bioassay Scientist for two years, having joined the company after completing her PhD. She has always been interested in science from a young age and was particularly fascinated by biology and the sheer amount that is going on inside our body that most people are unaware of. […]
International Day of Women and Girls in Science 2026
International Day of Women and Girls in Science is an annual observance that celebrates the achievements and contributions of women and girls in the fields of science, technology, engineering, and mathematics (STEM). This day recognises the importance of gender equality and the empowerment of women and girls in the scientific community. To mark the occasion, […]
Rheumatoid Arthritis Awareness Day
Rheumatoid Arthritis Awareness Day is observed annually on 2 February and is a vital initiative aimed at spreading awareness about rheumatoid arthritis, an autoimmune disease that affects millions of people worldwide. In this blog the Cellomatics team discuss the disease and how we study it using a multi-parametric approach to provide deeper insight. Rheumatoid Arthritis […]
Meet the team: Thomas Cox
Thomas has been interested in life sciences since taking the GCSE History module ‘Medicine in Britain, c.1250 to present day’ where he learnt about the evolution of medical treatments and the individuals who helped to pioneer scientific breakthroughs. He was fascinated by how much our understanding of diseases can change over time, leading to better […]
Cellomatics 2025: a year of growth, innovation, and new opportunities
With 2025 coming to an end, we sat down with CEO and founder of Cellomatics Biosciences, Dr Shailendra Singh, to get his thoughts on the previous twelve months and his view of where he thinks Cellomatics will be in 2026. As we approach the end of another impactful year, I am pleased to reflect on […]
Meet the team: Huan Thompson
Huan Thompson joined Cellomatics in January 2024, having completed her MSc in Cancer Immunology and Biotechnology at the University of Nottingham the previous year. She is currently working as an Associate Scientist II at Cellomatics and is keen to progress further in her role. In our latest blog we discuss Huan’s passion for science, her […]
Beyond GLP: how non-GLP CROs support clinical development
There’s a common misconception that only GLP-compliant Contract Research Organisations (CROs) can meaningfully support clinical development. In reality, many pharma and biotech teams rely on non-GLP laboratories for a wide range of translational and clinical-support studies—unlocking speed, flexibility, and actionable insights that accelerate decision-making. While GLP compliance remains essential for pivotal non-clinical safety studies, numerous […]
Organoids: unlocking new possibilities
The preclinical drug testing landscape is undergoing a profound transformation. For decades, drug development has depended heavily on animal models and simple two-dimensional (2D) cell cultures to evaluate the safety and efficacy of new compounds before they reach human trials. While these traditional models have been instrumental in advancing medicine, they often fail to fully […]